NATCO Pharma Limited (NATCOPHARM.NS)

INR 765.85

(-3.88%)

Long Term Debt Summary of NATCO Pharma Limited

  • NATCO Pharma Limited's latest annual long term debt in 2023 was 53 Million INR , up 381.82% from previous year.
  • NATCO Pharma Limited's latest quarterly long term debt in 2023 FY was 53 Million INR , up 381.82% from previous quarter.
  • NATCO Pharma Limited reported annual long term debt of 11 Million INR in 2022, down -86.25% from previous year.
  • NATCO Pharma Limited reported annual long term debt of 80 Million INR in 2021, up 788.89% from previous year.
  • NATCO Pharma Limited reported quarterly long term debt of 53 Million INR for 2023 FY, up 381.82% from previous quarter.
  • NATCO Pharma Limited reported quarterly long term debt of 62 Million INR for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of NATCO Pharma Limited (2023 - 2004)

Historical Annual Long Term Debt of NATCO Pharma Limited (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 53 Million INR 381.82%
2022 11 Million INR -86.25%
2021 80 Million INR 788.89%
2020 9 Million INR 0.0%
2019 9 Million INR 0.0%
2018 - INR 0.0%
2017 - INR 0.0%
2016 - INR 0.0%
2015 - INR -100.0%
2014 970.15 Million INR 1.6%
2013 954.86 Million INR -30.72%
2012 1.37 Billion INR 2.78%
2011 1.34 Billion INR -39.04%
2010 2.19 Billion INR 84.07%
2009 1.19 Billion INR -5.41%
2008 1.26 Billion INR 34.21%
2007 941.33 Million INR 23.15%
2006 764.36 Million INR -4.52%
2005 800.52 Million INR -28.03%
2004 1.11 Billion INR 0.0%

Peer Long Term Debt Comparison of NATCO Pharma Limited

Name Long Term Debt Long Term Debt Difference
Alembic Pharmaceuticals Limited 628.8 Million INR 91.571%
Bafna Pharmaceuticals Limited 107.53 Million INR 50.712%
FDC Limited 2.46 Million INR -2049.23%
Gufic Biosciences Limited 1.53 Billion INR 96.558%
Jubilant Pharmova Limited 31.67 Billion INR 99.833%
Nectar Lifesciences Limited 1.4 Billion INR 96.223%
Orchid Pharma Limited 1.2 Billion INR 95.599%
Alkem Laboratories Limited 400 Million INR 86.75%
Bajaj HealthCare Limited 650.34 Million INR 91.85%
Brooks Laboratories Limited 3.56 Million INR -1386.676%
Eris Lifesciences Limited 6.54 Billion INR 99.19%
Glenmark Life Sciences Limited 147.61 Million INR 64.095%
Solara Active Pharma Sciences Limited 1.17 Billion INR 95.487%
Innova Captab Limited 2.1 Billion INR 97.482%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 29.866%
Wanbury Limited 820 Million INR 93.537%
Lupin Limited 1.55 Billion INR 96.587%
Aarti Drugs Limited 2.75 Billion INR 98.075%
Aarti Pharmalabs Limited 400 Thousand INR -13150.0%
Albert David Limited 6.01 Million INR -780.984%
Alembic Limited 73.9 Million INR 28.281%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
Hester Biosciences Limited 1.81 Billion INR 97.084%
Hikal Limited 4.22 Billion INR 98.747%
Ind-Swift Laboratories Limited 111.62 Million INR 52.52%
Ind-Swift Limited 10.09 Billion INR 99.475%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Kilitch Drugs (India) Limited - INR -Infinity%
Lincoln Pharmaceuticals Limited - INR -Infinity%
Mangalam Drugs & Organics Limited 133.54 Million INR 60.312%
Medico Remedies Limited 8.67 Million INR -511.162%
Morepen Laboratories Limited 33.64 Million INR -57.551%
Procter & Gamble Health Limited 68.8 Million INR 22.965%
RPG Life Sciences Limited -30.3 Million INR 274.917%
Sigachi Industries Limited 265.79 Million INR 80.06%
Sun Pharmaceutical Industries Limited 13.3 Million INR -298.496%
Suven Pharmaceuticals Limited 212.35 Million INR 75.042%
Themis Medicare Limited 267.74 Million INR 80.205%
Unichem Laboratories Limited 382.22 Million INR 86.134%
Vaishali Pharma Limited 35.98 Million INR -47.292%
Venus Remedies Limited 386.8 Million INR 86.298%
Windlas Biotech Limited 20.18 Million INR -162.636%
ZIM Laboratories Limited 356 Million INR 85.113%
Sakar Healthcare Limited 549.55 Million INR 90.356%
Aurobindo Pharma Limited 21.34 Billion INR 99.752%
Divi's Laboratories Limited 20 Million INR -165.0%
AstraZeneca Pharma India Limited 27.83 Million INR -90.401%
Mankind Pharma Limited 325.81 Million INR 83.733%
Sequent Scientific Limited 1.42 Billion INR 96.286%
Laurus Labs Limited 7.98 Billion INR 99.336%
Neuland Laboratories Limited 449.2 Million INR 88.201%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 77.58%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 96.506%
Zydus Lifesciences Limited 251 Million INR 78.884%
Amrutanjan Health Care Limited 13.96 Million INR -279.439%
Wockhardt Limited 8.91 Billion INR 99.405%
Bal Pharma Limited 363.82 Million INR 85.433%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.115%
Bliss GVS Pharma Limited 355.92 Million INR 85.109%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 9.2 Million INR -476.087%
Shilpa Medicare Limited 5.6 Billion INR 99.054%
Valiant Laboratories Limited 750.89 Million INR 92.942%
Ajanta Pharma Limited 235.2 Million INR 77.466%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR -64.373%
Granules India Limited 689.71 Million INR 92.316%
Medicamen Biotech Limited 12.55 Million INR -322.143%
Ipca Laboratories Limited 5.8 Billion INR 99.087%
Syncom Formulations (India) Limited -1.21 Million INR 4447.826%
Piramal Enterprises Limited 535.85 Billion INR 99.99%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.67%
Suven Life Sciences Limited - INR -Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 97.112%
Strides Pharma Science Limited 6.71 Billion INR 99.211%
Indoco Remedies Limited 3.51 Billion INR 98.493%
Alpa Laboratories Limited - INR -Infinity%
Lasa Supergenerics Limited - INR -Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 50.281%